Transcriptionally Active Lung Microbiome and Its Association with Bacterial Biomass and Host Inflammatory Status

mSystems

Volumn 3, Issue 5, 2018, Pages

  Ren, Lili ^a   Zhang, Rongbao ^b   Rao, Jian ^a   Xiao, Yan ^a   Zhang, Zhao ^b   Yang, Bin ^a   Cao, Depan ^a   Zhong, Hui ^a   Ning, Pu ^b   Shang, Ying ^b   Li, Mingkun ^c,d,e   Gao, Zhancheng ^b   Wang, Jianwei ^a  

^a INSTITUTE OF PATHOGEN BIOLOGY   (China)

^b PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

^c China National Center for Bioinformation   (China)

^d Fondation Mérieux Applied Research   (France)

^e INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

Author keywords

Airborne microorganisms; Bacterial biomass; Lung microbiome; Lung microbiota; Metatranscriptome; Microbial communities

Indexed keywords

EID: 85071413001     PISSN: None     EISSN: 23795077     Source Type: Journal    
DOI: 10.1128/MSYSTEMS.00199-18     Document Type: Article

References (59)

1. Man WH, de Steenhuijsen Piters WA, Bogaert D. 2017. The microbiota of the respiratory tract: gatekeeper to respiratory health. Nat Rev Microbiol 15:259–270. https://doi.org/10.1038/nrmicro.2017.14.
2. Dickson RP, Erb-Downward JR, Freeman CM, McCloskey L, Beck JM, Huffnagle GB, Curtis JL. 2015. Spatial variation in the healthy human lung microbiome and the adapted island model of lung biogeography. Ann Am Thorac Soc 12:821–830. https://doi.org/10.1513/AnnalsATS.201501-029OC.
3. Park H, Shin JW, Park SG, Kim W. 2014. Microbial communities in the upper respiratory tract of patients with asthma and chronic obstructive pulmonary disease. PLoS One 9:e109710. https://doi.org/10.1371/journal.pone.0109710.
4. Huang YJ, Nariya S, Harris JM, Lynch SV, Choy DF, Arron JR, Boushey H. 2015. The airway microbiome in patients with severe asthma: associations with disease features and severity. J Allergy Clin Immunol 136: 874–884. https://doi.org/10.1016/j.jaci.2015.05.044.
5. Carmody LA, Zhao J, Schloss PD, Petrosino JF, Murray S, Young VB, Li JZ, LiPuma JJ. 2013. Changes in cystic fibrosis airway microbiota at pulmonary exacerbation. Ann Am Thorac Soc 10:179–187. https://doi.org/10.1513/AnnalsATS.201211-107OC.
6. Maurice CF, Haiser HJ, Turnbaugh PJ. 2013. Xenobiotics shape the physiology and gene expression of the active human gut microbiome. Cell 152:39–50. https://doi.org/10.1016/j.cell.2012.10.052.
7. McNulty NP, Yatsunenko T, Hsiao A, Faith JJ, Muegge BD, Goodman AL, Henrissat B, Oozeer R, Cools-Portier S, Gobert G, Chervaux C, Knights D, Lozupone CA, Knight R, Duncan AE, Bain JR, Muehlbauer MJ, Newgard CB, Heath AC, Gordon JI. 2011. The impact of a consortium of fermented milk strains on the gut microbiome of gnotobiotic mice and mono-zygotic twins. Sci Transl Med 3:106ra106. https://doi.org/10.1126/scitranslmed.3002701.
8. Cameron SJ, Lewis KE, Huws SA, Lin W, Hegarty MJ, Lewis PD, Mur LA, Pachebat JA. 2016. Metagenomic sequencing of the chronic obstructive pulmonary disease upper bronchial tract microbiome reveals functional changes associated with disease severity. PLoS One 11:e0149095. https://doi.org/10.1371/journal.pone.0149095.
9. Millares L, Pérez-Brocal V, Ferrari R, Gallego M, Pomares X, García-Núñez M, Montón C, Capilla S, Monsó E, Moya A. 2015. Functional metagenomics of the bronchial microbiome in COPD. PLoS One 10:e0144448. https://doi.org/10.1371/journal.pone.0144448.
10. Franzosa EA, Morgan XC, Segata N, Waldron L, Reyes J, Earl AM, Giannoukos G, Boylan MR, Ciulla D, Gevers D, Izard J, Garrett WS, Chan AT, Huttenhower C. 2014. Relating the metatranscriptome and metagenome of the human gut. Proc Natl Acad Sci U S A 111:E2329 –E2338. https://doi.org/10.1073/pnas.1319284111.
11. Abu-Ali GS, Mehta RS, Lloyd-Price J, Mallick H, Branck T, Ivey KL, Drew DA, DuLong C, Rimm E, Izard J, Chan AT, Huttenhower C. 2018. Metatranscriptome of human faecal microbial communities in a cohort of adult men. Nat Microbiol 3:356 –366. https://doi.org/10.1038/s41564-017 -0084-4.
12. Lee SW, Kuan CS, Wu LS, Weng JT. 2016. Metagenome and metatranscriptome profiling of moderate and severe COPD sputum in Taiwanese Han males. PLoS One 11:e0159066. https://doi.org/10.1371/journal.pone.0159066.
13. Westermann AJ, Barquist L, Vogel J. 2017. Resolving host-pathogen interactions by dual RNA-seq. PLoS Pathog 13:e1006033. https://doi.org/10.1371/journal.ppat.1006033.
14. World Health Organization (WHO). 2008. The global burden of disease: 2004 update. WHO Press, Geneva, Switzerland.
15. Wang Z, Bafadhel M, Haldar K, Spivak A, Mayhew D, Miller BE, Tal-Singer R, Johnston SL, Ramsheh MY, Barer MR, Brightling CE, Brown JR. 2016. Lung microbiome dynamics in COPD exacerbations. Eur Respir J 47: 1082–1092. https://doi.org/10.1183/13993003.01406-2015.
16. Huang YJ, Erb-Downward JR, Dickson RP, Curtis JL, Huffnagle GB, Han MK. 2017. Understanding the role of the microbiome in chronic obstructive pulmonary disease: principles, challenges, and future directions. Transl Res 179:71–83. https://doi.org/10.1016/j.trsl.2016.06.007.
17. Mayhew D, Devos N, Lambert C, Brown JR, Clarke SC, Kim VL, Magid-Slav M, Miller BE, Ostridge KK, Patel R, Sathe G, Simola DF, Staples KJ, Sung R, Tal-Singer R, Tuck AC, Van Horn S, Weynants V, Williams NP, Devaster JM, Wilkinson TMA, AERIS Study Group. 31 January 2018. Longitudinal profiling of the lung microbiome in the AERIS study demonstrates repeatability of bacterial and eosinophilic COPD exacerbations. Thorax https://doi.org/10.1136/thoraxjnl-2017-210408.
18. Erb-Downward JR, Thompson DL, Han MK, Freeman CM, McCloskey L, Schmidt LA, Young VB, Toews GB, Curtis JL, Sundaram B, Martinez FJ, Huffnagle GB. 2011. Analysis of the lung microbiome in the “healthy” smoker and in COPD. PLoS One 6:e16384. https://doi.org/10.1371/journal.pone.0016384.
19. Sze MA, Dimitriu PA, Hayashi S, Elliott WM, McDonough JE, Gosselink JV, Cooper J, Sin DD, Mohn WW, Hogg JC. 2012. The lung tissue microbiome in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 185:1073–1080. https://doi.org/10.1164/rccm.201111-2075OC.
20. Pragman AA, Kim HB, Reilly CS, Wendt C, Isaacson RE. 2012. The lung microbiome in moderate and severe chronic obstructive pulmonary disease. PLoS One 7:e47305. https://doi.org/10.1371/journal.pone.0047305.
21. Huang YJ, Sethi S, Murphy T, Nariya S, Boushey HA, Lynch SV. 2014. Airway microbiome dynamics in exacerbations of chronic obstructive pulmonary disease. J Clin Microbiol 52:2813–2823. https://doi.org/10.1128/JCM.00035-14.
22. Einarsson GG, Comer DM, McIlreavey L, Parkhill J, Ennis M, Tunney MM, Elborn JS. 2016. Community dynamics and the lower airway microbiota in stable chronic obstructive pulmonary disease, smokers and healthy non-smokers. Thorax 71:795–803. https://doi.org/10.1136/thoraxjnl-2015 -207235.
23. Salter SJ, Cox MJ, Turek EM, Calus ST, Cookson WO, Moffatt MF, Turner P, Parkhill J, Loman NJ, Walker AW. 2014. Reagent and laboratory contamination can critically impact sequence-based microbiome analyses. BMC Biol 12:87. https://doi.org/10.1186/s12915-014-0087-z.
24. Garcia-Vidal C, Almagro P, Romani V, Rodriguez-Carballeira M, Cuchi E, Canales L, Blasco D, Heredia JL, Garau J. 2009. Pseudomonas aeruginosa in patients hospitalised for COPD exacerbation: a prospective study. Eur Respir J 34:1072–1078. https://doi.org/10.1183/09031936.00003309.
25. Murphy TF. 2008. The many faces of Pseudomonas aeruginosa in chronic obstructive pulmonary disease. Clin Infect Dis 47:1534 –1536. https://doi.org/10.1086/593187.
26. Martinez-Solano L, Macia MD, Fajardo A, Oliver A, Martinez JL. 2008. Chronic Pseudomonas aeruginosa infection in chronic obstructive pulmonary disease. Clin Infect Dis 47:1526–1533. https://doi.org/10.1086/ 593186.
27. Collins AM, Rylance J, Wootton DG, Wright AD, Wright AK, Fullerton DG, Gordon SB. 24 March 2014. Bronchoalveolar lavage (BAL) for research; obtaining adequate sample yield. J Vis Exp https://doi.org/10.3791/4345.
28. Masopust D, Schenkel JM. 2013. The integration of T cell migration, differentiation and function. Nat Rev Immunol 13:309–320. https://doi.org/10.1038/nri3442.
29. Segal LN, Clemente JC, Tsay JC, Koralov SB, Keller BC, Wu BG, Li Y, Shen N, Ghedin E, Morris A, Diaz P, Huang L, Wikoff WR, Ubeda C, Artacho A, Rom WN, Sterman DH, Collman RG, Blaser MJ, Weiden MD. 2016. Enrichment of the lung microbiome with oral taxa is associated with lung inflammation of a Th17 phenotype. Nat Microbiol 1:16031. https://doi.org/10.1038/nmicrobiol.2016.31.
30. Shenoy MK, Iwai S, Lin DL, Worodria W, Ayakaka I, Byanyima P, Kaswabuli S, Fong S, Stone S, Chang E, Davis JL, Faruqi AA, Segal MR, Huang L, Lynch SV. 2017. Immune response and mortality risk relate to distinct lung microbiomes in patients with HIV and pneumonia. Am J Respir Crit Care Med 195:104 –114. https://doi.org/10.1164/rccm.201603-0523OC.
31. Sze MA, Hogg JC, Sin DD. 2014. Bacterial microbiome of lungs in COPD. Int J Chron Obstruct Pulmon Dis 9:229–238.
32. Paju S, Scannapieco FA. 2007. Oral biofilms, periodontitis, and pulmonary infections. Oral Dis 13:508–512. https://doi.org/10.1111/j.1601-0825.2007.01410a.x.
33. Segal LN, Alekseyenko AV, Clemente JC, Kulkarni R, Wu B, Gao Z, Chen H, Berger KI, Goldring RM, Rom WN, Blaser MJ, Weiden MD. 2013. Enrichment of lung microbiome with supraglottic taxa is associated with increased pulmonary inflammation. Microbiome 1:19. https://doi.org/10.1186/2049-2618-1-19.
34. Arumugam M, Raes J, Pelletier E, Le Paslier D, Yamada T, Mende DR, Fernandes GR, Tap J, Bruls T, Batto J-M, Bertalan M, Borruel N, Casellas F, Fernandez L, Gautier L, Hansen T, Hattori M, Hayashi T, Kleerebezem M, Kurokawa K, Leclerc M, Levenez F, Manichanh C, Nielsen HB, Nielsen T, Pons N, Poulain J, Qin J, Sicheritz-Ponten T, Tims S, Torrents D, Ugarte E, Zoetendal EG, Wang J, Guarner F, Pedersen O, de Vos WM, Brunak S, Doré J, Antolín M, Artiguenave F, Blottiere HM, Almeida M, Brechot C, Cara C, Chervaux C, Cultrone A, Delorme C, Denariaz G, et al. 2011. Enterotypes of the human gut microbiome. Nature 473:174–180. https://doi.org/10.1038/nature09944.
35. Oh J, Byrd AL, Deming C, Conlan S, NISC Comparative Sequencing Program, Kong HH, Segre JA. 2014. Biogeography and individuality shape function in the human skin metagenome. Nature 514:59–64. https://doi.org/10.1038/nature13786.
36. Gajer P, Brotman RM, Bai G, Sakamoto J, Schutte UM, Zhong X, Koenig SS, Fu L, Ma ZS, Zhou X, Abdo Z, Forney LJ, Ravel J. 2012. Temporal dynamics of the human vaginal microbiota. Sci Transl Med 4:132ra52. https://doi.org/10.1126/scitranslmed.3003605.
37. Curtis MM, Way SS. 2009. Interleukin-17 in host defence against bacterial, mycobacterial and fungal pathogens. Immunology 126:177–185. https://doi.org/10.1111/j.1365-2567.2008.03017.x.
38. Vandeputte D, Kathagen G, D’Hoe K, Vieira-Silva S, Valles-Colomer M, Sabino J, Wang J, Tito RY, De Commer L, Darzi Y, Vermeire S, Falony G, Raes J. 2017. Quantitative microbiome profiling links gut community variation to microbial load. Nature 551:507–511. https://doi.org/10.1038/ nature24460.
39. Mourani PM, Harris JK, Sontag MK, Robertson CE, Abman SH. 2011. Molecular identification of bacteria in tracheal aspirate fluid from mechanically ventilated preterm infants. PLoS One 6:e25959. https://doi.org/10.1371/journal.pone.0025959.
40. Coenye T, Vandamme P, LiPuma JJ. 2002. Infection by Ralstonia species in cystic fibrosis patients: identification of R. pickettii and R. mannitolilytica by polymerase chain reaction. Emerg Infect Dis 8:692–696. https://doi.org/10.3201/eid0807.010472.
41. Berman JS, Beer DJ, Theodore AC, Kornfeld H, Bernardo J, Center DM. 1990. Lymphocyte recruitment to the lung. Am Rev Respir Dis 142: 238–257. https://doi.org/10.1164/ajrccm/142.1.238.
42. He Q, Viljanen MK, Arvilommi H, Aittanen B, Mertsola J. 1998. Whooping cough caused by Bordetella pertussis and Bordetella parapertussis in an immunized population. JAMA 280:635–637. https://doi.org/10.1001/jama.280.7.635.
43. Hashemi SH, Nadi E, Hajilooi M, Seif-Rabiei MA, Samaei A. 2015. High seroprevalence of Bordetella pertussis in patients with chronic obstructive pulmonary disease: a case-control study. Tanaffos 14:172–176.
44. Carbonetti NH, Artamonova GV, Mays RM, Worthington ZE. 2003. Pertussis toxin plays an early role in respiratory tract colonization by Bordetella pertussis. Infect Immun 71:6358–6366. https://doi.org/10.1128/IAI.71.11.6358-6366.2003.
45. Bolger AM, Lohse M, Usadel B. 2014. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics 30:2114–2120. https://doi.org/10.1093/bioinformatics/btu170.
46. Langmead B, Salzberg SL. 2012. Fast gapped-read alignment with Bowtie 2. Nat Methods 9:357–359. https://doi.org/10.1038/nmeth.1923.
47. Kopylova E, Noe L, Touzet H. 2012. SortMeRNA: fast and accurate filtering of ribosomal RNAs in metatranscriptomic data. Bioinformatics 28:3211–3217. https://doi.org/10.1093/bioinformatics/bts611.
48. Peng Y, Leung HC, Yiu SM, Chin FY. 2012. IDBA-UD: a de novo assembler for single-cell and metagenomic sequencing data with highly uneven depth. Bioinformatics 28:1420 –1428. https://doi.org/10.1093/bioinformatics/ bts174.
49. Boisvert S, Raymond F, Godzaridis E, Laviolette F, Corbeil J. 2012. Ray Meta: scalable de novo metagenome assembly and profiling. Genome Biol 13:R122. https://doi.org/10.1186/gb-2012-13-12-r122.
50. Haas BJ, Papanicolaou A, Yassour M, Grabherr M, Blood PD, Bowden J, Couger MB, Eccles D, Li B, Lieber M, Macmanes MD, Ott M, Orvis J, Pochet N, Strozzi F, Weeks N, Westerman R, William T, Dewey CN, Henschel R, Leduc RD, Friedman N, Regev A. 2013. De novo transcript sequence reconstruction from RNA-seq using the Trinity platform for reference generation and analysis. Nat Protoc 8:1494–1512. https://doi.org/10.1038/nprot.2013.084.
51. Luo R, Liu B, Xie Y, Li Z, Huang W, Yuan J, He G, Chen Y, Pan Q, Liu Y, Tang J, Wu G, Zhang H, Shi Y, Liu Y, Yu C, Wang B, Lu Y, Han C, Cheung DW, Yiu SM, Peng S, Xiaoqian Z, Liu G, Liao X, Li Y, Yang H, Wang J, Lam TW, Wang J. 2012. SOAPdenovo2: an empirically improved memory-efficient short-read de novo assembler. Gigascience 1:18. https://doi.org/10.1186/2047-217X-1-18.
52. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. 1990. Basic local alignment search tool. J Mol Biol 215:403–410. https://doi.org/10.1016/ S0022-2836(05)80360-2.
53. Huson DH, Beier S, Flade I, Gorska A, El-Hadidi M, Mitra S, Ruscheweyh HJ, Tappu R. 2016. MEGAN community edition - interactive exploration and analysis of large-scale microbiome sequencing data. PLoS Comput Biol 12:e1004957. https://doi.org/10.1371/journal.pcbi.1004957.
54. Buchfink B, Xie C, Huson DH. 2015. Fast and sensitive protein alignment using DIAMOND. Nat Methods 12:59–60. https://doi.org/10.1038/nmeth.3176.
55. Kanehisa M, Furumichi M, Tanabe M, Sato Y, Morishima K. 2017. KEGG: new perspectives on genomes, pathways, diseases and drugs. Nucleic Acids Res 45:D353–D361. https://doi.org/10.1093/nar/gkw1092.
56. Schloss PD, Westcott SL, Ryabin T, Hall JR, Hartmann M, Hollister EB, Lesniewski RA, Oakley BB, Parks DH, Robinson CJ, Sahl JW, Stres B, Thallinger GG, Van Horn DJ, Weber CF. 2009. Introducing mothur: open-source, platform-independent, community-supported software for describing and comparing microbial communities. Appl Environ Microbiol 75:7537–7541. https://doi.org/10.1128/AEM.01541-09.
57. Quast C, Pruesse E, Yilmaz P, Gerken J, Schweer T, Yarza P, Peplies J, Glockner FO. 2013. The SILVA ribosomal RNA gene database project: improved data processing and web-based tools. Nucleic Acids Res 41: D590–D596. https://doi.org/10.1093/nar/gks1219.
58. Storey JD, Tibshirani R. 2003. Statistical significance for genomewide studies. Proc Natl Acad Sci U S A 100:9440–9445. https://doi.org/10.1073/pnas.1530509100.
59. Benjamini Y, Hochberg Y. 1995. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B 57:289–300. https://www.jstor.org/stable/2346101.